BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 31300419)

  • 1. Sporadic and endemic Burkitt lymphoma have frequent
    Zhou P; Blain AE; Newman AM; Zaka M; Chagaluka G; Adlar FR; Offor UT; Broadbent C; Chaytor L; Whitehead A; Hall A; O'Connor H; Van Noorden S; Lampert I; Bailey S; Molyneux E; Bacon CM; Bomken S; Rand V
    Blood Adv; 2019 Jul; 3(14):2118-2127. PubMed ID: 31300419
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr virus status of sporadic Burkitt lymphoma is associated with patient age and mutational features.
    Richter J; John K; Staiger AM; Rosenwald A; Kurz K; Michgehl U; Ott G; Franzenburg S; Kohler C; Finger J; Oschlies I; Paul U; Siebert R; Spang R; Burkhardt B; Klapper W
    Br J Haematol; 2022 Feb; 196(3):681-689. PubMed ID: 34617271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nuclear FOXO1 promotes lymphomagenesis in germinal center B cells.
    Kabrani E; Chu VT; Tasouri E; Sommermann T; Baßler K; Ulas T; Zenz T; Bullinger L; Schultze JL; Rajewsky K; Sander S
    Blood; 2018 Dec; 132(25):2670-2683. PubMed ID: 30333121
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Burkitt lymphoma pathogenesis and therapeutic targets from structural and functional genomics.
    Schmitz R; Young RM; Ceribelli M; Jhavar S; Xiao W; Zhang M; Wright G; Shaffer AL; Hodson DJ; Buras E; Liu X; Powell J; Yang Y; Xu W; Zhao H; Kohlhammer H; Rosenwald A; Kluin P; Müller-Hermelink HK; Ott G; Gascoyne RD; Connors JM; Rimsza LM; Campo E; Jaffe ES; Delabie J; Smeland EB; Ogwang MD; Reynolds SJ; Fisher RI; Braziel RM; Tubbs RR; Cook JR; Weisenburger DD; Chan WC; Pittaluga S; Wilson W; Waldmann TA; Rowe M; Mbulaiteye SM; Rickinson AB; Staudt LM
    Nature; 2012 Oct; 490(7418):116-20. PubMed ID: 22885699
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The mutational landscape of Burkitt-like lymphoma with 11q aberration is distinct from that of Burkitt lymphoma.
    Wagener R; Seufert J; Raimondi F; Bens S; Kleinheinz K; Nagel I; Altmüller J; Thiele H; Hübschmann D; Kohler CW; Nürnberg P; Au-Yeung R; Burkhardt B; Horn H; Leoncini L; Jaffe ES; Ott G; Rymkiewicz G; Schlesner M; Russell RB; Klapper W; Siebert R
    Blood; 2019 Feb; 133(9):962-966. PubMed ID: 30567752
    [TBL] [Abstract][Full Text] [Related]  

  • 6. B-cell differentiation in EBV-positive Burkitt lymphoma is impaired at posttranscriptional level by miRNA-altered expression.
    Leucci E; Onnis A; Cocco M; De Falco G; Imperatore F; Giuseppina A; Costanzo V; Cerino G; Mannucci S; Cantisani R; Nyagol J; Mwanda W; Iriso R; Owang M; Schurfeld K; Bellan C; Lazzi S; Leoncini L
    Int J Cancer; 2010 Mar; 126(6):1316-26. PubMed ID: 19530237
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Burkitt lymphoma-related
    Yamazaki T; Liu L; Conlon EG; Manley JL
    RNA Biol; 2020 Oct; 17(10):1383-1390. PubMed ID: 32449435
    [TBL] [Abstract][Full Text] [Related]  

  • 8. B-cell lymphomas with concurrent IGH-BCL2 and MYC rearrangements are aggressive neoplasms with clinical and pathologic features distinct from Burkitt lymphoma and diffuse large B-cell lymphoma.
    Snuderl M; Kolman OK; Chen YB; Hsu JJ; Ackerman AM; Dal Cin P; Ferry JA; Harris NL; Hasserjian RP; Zukerberg LR; Abramson JS; Hochberg EP; Lee H; Lee AI; Toomey CE; Sohani AR
    Am J Surg Pathol; 2010 Mar; 34(3):327-40. PubMed ID: 20118770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Genome-wide discovery of somatic coding and noncoding mutations in pediatric endemic and sporadic Burkitt lymphoma.
    Grande BM; Gerhard DS; Jiang A; Griner NB; Abramson JS; Alexander TB; Allen H; Ayers LW; Bethony JM; Bhatia K; Bowen J; Casper C; Choi JK; Culibrk L; Davidsen TM; Dyer MA; Gastier-Foster JM; Gesuwan P; Greiner TC; Gross TG; Hanf B; Harris NL; He Y; Irvin JD; Jaffe ES; Jones SJM; Kerchan P; Knoetze N; Leal FE; Lichtenberg TM; Ma Y; Martin JP; Martin MR; Mbulaiteye SM; Mullighan CG; Mungall AJ; Namirembe C; Novik K; Noy A; Ogwang MD; Omoding A; Orem J; Reynolds SJ; Rushton CK; Sandlund JT; Schmitz R; Taylor C; Wilson WH; Wright GW; Zhao EY; Marra MA; Morin RD; Staudt LM
    Blood; 2019 Mar; 133(12):1313-1324. PubMed ID: 30617194
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clonality Analysis of Immunoglobulin Gene Rearrangement by Next-Generation Sequencing in Endemic Burkitt Lymphoma Suggests Antigen Drive Activation of BCR as Opposed to Sporadic Burkitt Lymphoma.
    Amato T; Abate F; Piccaluga P; Iacono M; Fallerini C; Renieri A; De Falco G; Ambrosio MR; Mourmouras V; Ogwang M; Calbi V; Rabadan R; Hummel M; Pileri S; Leoncini L; Bellan C
    Am J Clin Pathol; 2016 Jan; 145(1):116-27. PubMed ID: 26712879
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Immunoglobulin gene analysis reveals 2 distinct cells of origin for EBV-positive and EBV-negative Burkitt lymphomas.
    Bellan C; Lazzi S; Hummel M; Palummo N; de Santi M; Amato T; Nyagol J; Sabattini E; Lazure T; Pileri SA; Raphael M; Stein H; Tosi P; Leoncini L
    Blood; 2005 Aug; 106(3):1031-6. PubMed ID: 15840698
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Molecular genetic features of sporadic Burkitt's lymphoma in children].
    Yang WP; Huang H; Gong LP; Wu Y; Xu HY; Zou Y; Lü BB; Zhong HS; Deng QQ; Xiao Q; Zeng ST; Zhu CD
    Zhonghua Bing Li Xue Za Zhi; 2010 Dec; 39(12):819-24. PubMed ID: 21215097
    [TBL] [Abstract][Full Text] [Related]  

  • 13. BI6727, a polo-like kinase 1 inhibitor with promising efficacy on Burkitt lymphoma cells.
    Chen E; Pei R
    J Int Med Res; 2020 May; 48(5):300060520926093. PubMed ID: 32468878
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inactivation of the ARF-MDM-2-p53 pathway in sporadic Burkitt's lymphoma in children.
    Wilda M; Bruch J; Harder L; Rawer D; Reiter A; Borkhardt A; Woessmann W
    Leukemia; 2004 Mar; 18(3):584-8. PubMed ID: 14712292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. DNA methylome analysis in Burkitt and follicular lymphomas identifies differentially methylated regions linked to somatic mutation and transcriptional control.
    Kretzmer H; Bernhart SH; Wang W; Haake A; Weniger MA; Bergmann AK; Betts MJ; Carrillo-de-Santa-Pau E; Doose G; Gutwein J; Richter J; Hovestadt V; Huang B; Rico D; Jühling F; Kolarova J; Lu Q; Otto C; Wagener R; Arnolds J; Burkhardt B; Claviez A; Drexler HG; Eberth S; Eils R; Flicek P; Haas S; Humme M; Karsch D; Kerstens HHD; Klapper W; Kreuz M; Lawerenz C; Lenzek D; Loeffler M; López C; MacLeod RAF; Martens JHA; Kulis M; Martín-Subero JI; Möller P; Nage I; Picelli S; Vater I; Rohde M; Rosenstiel P; Rosolowski M; Russell RB; Schilhabel M; Schlesner M; Stadler PF; Szczepanowski M; Trümper L; Stunnenberg HG; Küppers R; Ammerpohl O; Lichter P; Siebert R; Hoffmann S; Radlwimmer B
    Nat Genet; 2015 Nov; 47(11):1316-1325. PubMed ID: 26437030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inhibition of Hsp90 Suppresses PI3K/AKT/mTOR Signaling and Has Antitumor Activity in Burkitt Lymphoma.
    Giulino-Roth L; van Besien HJ; Dalton T; Totonchy JE; Rodina A; Taldone T; Bolaender A; Erdjument-Bromage H; Sadek J; Chadburn A; Barth MJ; Dela Cruz FS; Rainey A; Kung AL; Chiosis G; Cesarman E
    Mol Cancer Ther; 2017 Sep; 16(9):1779-1790. PubMed ID: 28619753
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FOXO1 forkhead domain mutants in B-cell lymphoma lack transcriptional activity.
    Sablon A; Bollaert E; Pirson C; Velghe AI; Demoulin JB
    Sci Rep; 2022 Jan; 12(1):1309. PubMed ID: 35079069
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Frequent expression of multiple myeloma 1/interferon regulatory factor 4 in Burkitt lymphoma.
    Gualco G; Queiroga EM; Weiss LM; Klumb CE; Harrington WJ; Bacchi CE
    Hum Pathol; 2009 Apr; 40(4):565-71. PubMed ID: 19144381
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A recurrent clonally distinct Burkitt lymphoma case highlights genetic key events contributing to oncogenesis.
    Penther D; Viailly PJ; Latour S; Etancelin P; Bohers E; Vellemans H; Camus V; Menard AL; Coutant S; Lanic H; Lemasle E; Drieux F; Veresezan L; Ruminy P; Raimbault A; Soulier J; Frebourg T; Tilly H; Jardin F
    Genes Chromosomes Cancer; 2019 Aug; 58(8):595-601. PubMed ID: 30779244
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Adult high-grade B-cell lymphoma with Burkitt lymphoma signature: genomic features and potential therapeutic targets.
    Bouska A; Bi C; Lone W; Zhang W; Kedwaii A; Heavican T; Lachel CM; Yu J; Ferro R; Eldorghamy N; Greiner TC; Vose J; Weisenburger DD; Gascoyne RD; Rosenwald A; Ott G; Campo E; Rimsza LM; Jaffe ES; Braziel RM; Siebert R; Miles RR; Dave S; Reddy A; Delabie J; Staudt LM; Song JY; McKeithan TW; Fu K; Green M; Chan WC; Iqbal J
    Blood; 2017 Oct; 130(16):1819-1831. PubMed ID: 28801451
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.